November 14, 2026 Understand what changes. Find what to use.

ModelsNews1 source

Google DeepMind says Antigravity identified an antimicrobial peptide candidate

Google DeepMind says it used Google Antigravity, its agentic development platform, to search for and evaluate candidates for new antimicrobial peptides. In an interactive session, researchers set the goal of finding peptides active against Streptococcus pseudopneumoniae, while the platform coordinated database searches, structural analyses and literature synthesis.

According to the company, the ProtNLM model helped examine millions of proteins with previously uncharacterized functions in the UniProt database, predicting biological functions from amino acid sequences. The identified candidate has predicted activity against pathogens involved in respiratory tract infections and is supported by structural and genomic evidence, but it still requires validation in laboratory experiments. Google DeepMind says the approach could speed up a process that is traditionally fragmented and labor-intensive.

Why it matters · editorial interpretation

The case suggests how agentic platforms could coordinate different stages of scientific discovery, reducing the fragmentation described by the company. Because the peptide’s activity is only predicted and still requires laboratory validation, the result does not yet represent a proven treatment.

Sources

ResearchAgents

One story, many sources

Coverage of the same story gathered in one item, with a link to each original.

Summary and interpretation apart

What the sources say stays in the summary; editorial context is labeled separately.

Always with the source

Every story links to the original articles, and the full content belongs to them.